Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    S. Karger AG ; 1983
    In:  International Archives of Allergy and Immunology Vol. 71, No. 4 ( 1983), p. 300-303
    In: International Archives of Allergy and Immunology, S. Karger AG, Vol. 71, No. 4 ( 1983), p. 300-303
    Kurzfassung: Blood samples of patients with severe respiratory allergic diseases contain increased numbers of T cells bearing surface HLA-DR antigens, indicating the presence of activated T cells. In the same group of patients, MLR3 and MLR4, two monoclonal antibodies (Mab) directed to subsets of activated peripheral T cells, recognize T cell percentages within the normal range. Thus, it seems possible that specialized subsets of activated T cells (HLA-DR 〈 sup 〉 + 〈 /sup 〉 /MLR3-MLR4 〈 sup 〉 –– 〈 /sup 〉 ) are represented in the peripheral blood of atopic patients. Such cells are lacking in patients after specific imunotherapy. Similar results – an increased percentage of 5/9 〈 sup 〉 + 〈 /sup 〉 T cells in untreated patients and normal counts of 5/9 〈 sup 〉 + 〈 /sup 〉 T cells in treated ones – were obtained in the two groups of patients by using another Mab, 5/9, which serves as a reliable marker of helper T cells in resting peripheral T lymphocytes. These data further support the concept of a T cell imbalance in allergic patients and suggest a possible role of specific immunotherapy in correcting the modification of peripheral T cell abnormalities.
    Materialart: Online-Ressource
    ISSN: 1018-2438 , 1423-0097
    RVK:
    Sprache: Englisch
    Verlag: S. Karger AG
    Publikationsdatum: 1983
    ZDB Id: 1482722-0
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz